Literature DB >> 21596582

Coexistent extra- and intracranial stenosis, cervical atherosclerosis, and abnormal ankle brachial index in acute ischemic stroke.

Disya Ratanakorn1, Jesada Keandoungchun, Charles H Tegeler.   

Abstract

BACKGROUND: There are limited data regarding abnormal ankle brachial index (ABI) with coexistent extracranial carotid stenosis (ECS), intracranial stenosis (ICS), and nonstenotic cervical atherosclerosis (CAS) in stroke, especially in Asia.
METHODS: We studied the prevalence of ECS, ICS, CAS, and combined ECS and ICS in 756 Thai patients with acute ischemic stroke and correlated sites of atherosclerosis with stroke risk factors and abnormal ABI.
RESULTS: The prevalence of ECS was 8.8%, ICS 52.6%, CAS 36.0%, abnormal ABI 18.8%, combined ECS and ICS 4.6%, combined ECS and abnormal ABI 2.8%, combined ICS and abnormal ABI 10.6%, and combined ECS, ICS, and abnormal ABI 1.6%. The prevalence of ECS, CAS, and combined ECS and ICS was higher in abnormal ABI compared to normal ABI (14.8% v 7.5% [P = .006]; 46.5% v 33.5% [P = .004], and 8.4% v 3.7% [P = .016], respectively). ECS was significantly correlated with history of coronary artery disease (CAD) and abnormal ABI; ICS with male gender, no alcohol use, and no atrial fibrillation; CAS with age ≥ 60 years, history of CAD and abnormal ABI; and combined ECS and ICS with history of CAD.
CONCLUSIONS: The frequency of atherosclerosis, especially ICS, was high. Cervicocerebral atherosclerosis was higher in abnormal ABI. This suggests that ischemic stroke patients should be screened for ECS, CAS, ICS, and abnormal ABI, especially in specific subsets (age ≥ 60 years, male gender, and history of CAD). The improved identification of vascular lesions could allow for a more optimal choice of antithrombotics, neurointervention, and more aggressive control of risk factors, potentially improving prevention of disease progression and a decrease in recurrent vascular events.
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21596582     DOI: 10.1016/j.jstrokecerebrovasdis.2011.04.006

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Increased pulsatility of the intracranial blood flow spectral waveform on transcranial Doppler does not point to peripheral arterial disease in stroke patients.

Authors:  Kristian Barlinn; Stanislava Kolieskova; Reza Bavarsad Shahripour; Jessica Kepplinger; Amelia K Boehme; Timo Siepmann; Volker Puetz; Ulf Bodechtel; William D Jordan; Andrei V Alexandrov
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-11-06       Impact factor: 2.136

2.  Association between Low Ankle-Brachial Index and Poor Outcomes in Patients with Embolic Stroke of Undetermined Source.

Authors:  Minho Han; JoonNyung Heo; Jae Wook Jung; Il Hyung Lee; Joon Ho Kim; Hyungwoo Lee; Young Dae Kim; Hyo Suk Nam
Journal:  J Clin Med       Date:  2022-05-29       Impact factor: 4.964

Review 3.  Factors Contributing to an Efficacious Endovascular Treatment for Acute Ischemic Stroke in Asian Population.

Authors:  Jin Soo Lee; Yang-Ha Hwang; Sung-Il Sohn
Journal:  Neurointervention       Date:  2021-03-26

4.  Relationship of thyroid function with intracranial arterial stenosis and carotid atheromatous plaques in ischemic stroke patients with euthyroidism.

Authors:  Junfeng Liu; Xiaoyang Cui; Deren Wang; Simiao Wu; Yao Xiong; Shihong Zhang; Bo Wu; Ming Liu
Journal:  Oncotarget       Date:  2017-07-11

5.  Risk factors associated with extracranial atherosclerosis in old patients with acute ischemic stroke.

Authors:  Lili Wang; Maolin He; Yun Zhang
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

6.  Impact of interankle blood pressure difference on major adverse cardiovascular events in cryptogenic stroke patients without peripheral artery disease: a retrospective cohort study.

Authors:  Minho Han; Minyoul Baik; Young Dae Kim; Junghye Choi; Kangsik Seo; Eunjeong Park; Ji Hoe Heo; Hyo Suk Nam
Journal:  BMJ Open       Date:  2022-02-23       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.